Reported Standalone quarterly numbers for Indoco Remedies are:
Net Sales at Rs 347.25 crore in March 2025 down 22.05% from Rs. 445.49 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 26.24 crore in March 2025 down 169.86% from Rs. 37.56 crore in March 2024.
EBITDA stands at Rs. 9.96 crore in March 2025 down 83.78% from Rs. 61.41 crore in March 2024.
Indoco Remedies shares closed at 261.58 on May 20, 2025 (NSE) and has given -12.75% returns over the last 6 months and -16.97% over the last 12 months.
Story continues below Advertisement
| Indoco Remedies | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 341.07 | 372.98 | 445.49 | | Other Operating Income | 6.18 | -- | -- | | Total Income From Operations | 347.25 | 372.98 | 445.49 | | EXPENDITURE | | Consumption of Raw Materials | 72.22 | 91.54 | 107.88 | | Purchase of Traded Goods | 30.62 | 34.94 | 27.17 | | Increase/Decrease in Stocks | -12.98 | -22.26 | 6.38 | | Power & Fuel | -- | -- | -- | | Employees Cost | 99.94 | 90.72 | 82.87 | | Depreciation | 24.88 | 24.75 | 23.73 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 153.99 | 157.90 | 163.83 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -21.42 | -4.61 | 33.63 | | Other Income | 6.50 | 4.26 | 4.05 | | P/L Before Int., Excpt. Items & Tax | -14.92 | -0.35 | 37.68 | | Interest | 15.98 | 14.00 | 10.91 | | P/L Before Exceptional Items & Tax | -30.90 | -14.35 | 26.77 | | Exceptional Items | -- | 0.99 | 19.73 | | P/L Before Tax | -30.90 | -13.36 | 46.50 | | Tax | -4.66 | -3.13 | 8.94 | | P/L After Tax from Ordinary Activities | -26.24 | -10.23 | 37.56 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -26.24 | -10.23 | 37.56 | | Equity Share Capital | 18.45 | 18.44 | 18.44 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.85 | -1.11 | 4.08 | | Diluted EPS | -2.85 | -1.11 | 4.07 | | EPS After Extra Ordinary | | Basic EPS | -2.84 | -1.11 | 4.08 | | Diluted EPS | -2.84 | -1.11 | 4.07 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
